| scholarly article | Q13442814 |
| P50 | author | Colleen Nelson | Q17517263 |
| P2093 | author name string | Ladan Fazli | |
| Martin E Gleave | |||
| Antonio Hurtado-Coll | |||
| Dmitry Turbin | |||
| Melanie L Lehman | |||
| Vanessa C Thompson | |||
| P2860 | cites work | Relaxin: a pleiotropic hormone | Q28235662 |
| P433 | issue | 10 | |
| P304 | page(s) | 1134-1145 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer | |
| P478 | volume | 70 |
| Q57105312 | Androgen receptor: what we know and what we expect in castration-resistant prostate cancer |
| Q44241131 | C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells |
| Q38501336 | Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis |
| Q35199287 | Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells |
| Q39093621 | Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy |
| Q97644181 | Protocadherins at the Crossroad of Signaling Pathways |
| Q58766683 | Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer |
| Q91767798 | Relaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling |
| Q39033904 | Relaxin-like peptides in male reproduction - a human perspective. |
| Q38080804 | Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein |
| Q38231840 | Targeting the relaxin hormonal pathway in prostate cancer. |
| Q38241850 | Wnt signaling in castration-resistant prostate cancer: implications for therapy |
Search more.